Exploring the Impact of Semaglutide on Cognitive Function and Anxiety-Related Behaviors in a Murine Model of Alzheimer’s Disease

Exploring the Impact of Semaglutide on Cognitive Function and Anxiety-Related Behaviors in a Murine Model of Alzheimer’s Disease

Background: Alzheimer’s disease (AD), the most prevalent form of dementia, is characterized by progressive cognitive decline and behavioral disturbances, with an increasing incidence as the global population ages. This study investigates the effects of semaglutide (SEM), a glucagon-like peptide-1 an...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ianis Kevyn Stefan Boboc, Petrica-Daniel Dumitrelea, Andreea Daniela Meca, Liliana Mititelu-Tartau, Maria Bogdan
Format:	Article
Language:	English
Published:	MDPI AG 2024-11-01
Series:	Biomedicines
Subjects:	semaglutide Alzheimer’s disease murine models open field test novel object recognition test social chamber test
Online Access:	https://www.mdpi.com/2227-9059/12/12/2689
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Microvascular dysfunction in a murine model of Alzheimer’s disease using intravital microscopy
by: Danielle Sidsworth, et al.
Published: (2025-02-01)

Spotlight on the Mechanism of Action of Semaglutide
by: Ilias Papakonstantinou, et al.
Published: (2024-12-01)

Reversible bilateral central scotoma under scotopic conditions associated with oral semaglutide
by: Peter Bracha, et al.
Published: (2024-12-01)

Effectiveness and Side Effect Incidence in a Real-World Digital Weight-Loss Service Using Compounded Semaglutide: A Retrospective Comparative Study
by: Louis Talay, et al.
Published: (2024-10-01)

A new tube chamber system for evaluation of anterior chamber pressure during phacoemulsification tested in porcine eyes
by: Fumiaki Higashijima, et al.
Published: (2025-01-01)

Race of GLPS: Impact on Weight and Glycemic Control on Type 2 Diabetes with Semaglutide Versus Liraglutide
by: Noha Hafeez, et al.
Published: (2024-12-01)

Semaglutide Reduces Cardiomyocyte Damage Caused by High-Fat Through HSDL2
by: Yang L, et al.
Published: (2024-11-01)

Insights into the Efficacy of GLP-1 Agonists and Dual Agonists: Semaglutide and Tirzepatide in Obesity and Type 2 Diabetes
by: Laura Opalska, et al.
Published: (2024-12-01)

Semaglutide, liraglutide and tirzepatide: Comparison of effectiveness in the treatment of obesity – a literature review
by: Karolina Baran, et al.
Published: (2024-12-01)

Semaglutide, type 2 diabetes, and the risk of nonarteritic anterior ischemic optic neuropathy
by: Fernando K. Malerbi, et al.
Published: (2025-01-01)

Real-world effectiveness of Semaglutide treatment on weight loss maintenance after weight loss in patients with obesity or overweight and diabetes
by: Michela Del Prete, et al.
Published: (2025-01-01)

Effects of Semaglutide Treatment on Psoriatic Lesions in Obese Patients with Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial
by: Jelena Petković-Dabić, et al.
Published: (2025-01-01)

Made in China: The international supply of illicit Semaglutide and weight-loss medicines online
by: Luke A. Turnock, et al.
Published: (2025-12-01)

Cardiometabolic Modulation by Semaglutide Contributes to Cardioprotection in Rats with Myocardial Infarction
by: Yan H, et al.
Published: (2024-11-01)

Development and Design Validation of an Inflow-Settling Chamber for Turbomachinery Test-Benches
by: Michael Henke, et al.
Published: (2024-09-01)

Effectiveness of Oral Semaglutide in Management of Type 2 Diabetes: A Real-World Study from India
by: Aditya Dutta, et al.
Published: (2024-12-01)

Automation of technological process of filling chambers during pneumatic vacuum tests
by: A. R. Aliev
Published: (2021-12-01)

Real-World Effectiveness of Oral Semaglutide in Indian Adult Diabetic Patients: Evaluation of EMR-based Data
by: Sandeep Gudibanda, et al.
Published: (2024-10-01)

Management of obesity with semaglutide or metformin in patients with antipsychotic-induced weight gain (MOSA): a non-randomised open-label pilot study
by: Bea Campforts, et al.
Published: (2024-11-01)

The Use of Nutraceutical and Pharmacological Strategies in Murine Models of Autism Spectrum Disorder
by: Matteo Bonetti, et al.
Published: (2024-12-01)

Case report: Long-term efficacy and safety of semaglutide in the treatment of syndromic obesity in Prader Willi syndrome - case series and literature review
by: Andrijana Koceva, et al.
Published: (2025-01-01)

Emission of Volatile Organic Compounds from Consumer Products
by: Kuo-Hsiung Lin, et al.
Published: (2022-08-01)

New chamber stapes prosthesis: Effect of ionizing radiation on material and functional properties
by: Kwacz Monika, et al.
Published: (2024-11-01)

Exploring factors that influence the behavior response to novel object tests in young thoroughbred horses: investigating sex, test site and auction history
by: Lara Klitzing, et al.
Published: (2025-01-01)

Towards reliable hyperspectral imaging biomarkers of CT26 murine tumor model
by: Tadej Tomanic, et al.
Published: (2024-11-01)

The Effects of Oral Semaglutide on Hepatic Fibrosis in Subjects with Type 2 Diabetes in Real-World Clinical Practice: A Post Hoc Analysis of the Sapporo-Oral SEMA Study
by: Hiroya Kitsunai, et al.
Published: (2025-01-01)

A novel non-invasive murine model for rapidly testing drug activity via inhalation administration against Mycobacterium tuberculosis
by: Xirong Tian, et al.
Published: (2025-01-01)

Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL‐AD preclinical testing core study
by: Kristen D. Onos, et al.
Published: (2022-01-01)

Análise Do Teste Cambridge Cognitive Examination (CAMCOG) Em Idosos Com 80 Anos Ou Mais Com E Sem Doença De Alzheimer
by: Lucas Gabriel Maltoni Romano, et al.
Published: (2024-11-01)

MIMO OTA performance testing of vehicles
by: Lei LI, et al.
Published: (2021-02-01)

Numerical study on flow and heat transfer of combustion chamber and turbine under thermal shock test
by: Cheng-jun Wang, et al.
Published: (2024-11-01)

Dexmedetomidine Attenuated Neuron Death, Cognitive Decline, and Anxiety-Like Behavior by Inhibiting CXCL2 in CA1 Region of AD Mice
by: Ma K, et al.
Published: (2024-11-01)

Etude du comportement exploratoire chez le microcèbe murin : corrélations entre personnalité et morphologie
by: Pauline Thomas, et al.
Published: (2016-01-01)

A phase 1b/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M1 receptor agonist HTL0018318 in patients with mild‐to‐moderate Alzheimer's disease
by: Pradeep J. Nathan, et al.
Published: (2022-01-01)

Deconstructing the Testing Mode Effect: Analyzing the Difference Between Writing and No Writing on the Test
by: Daniel M. Settlage, et al.
Published: (2024-06-01)

Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes
by: Jakob Grauslund, et al.
Published: (2024-12-01)

Efficacy and safety of once-weekly semaglutide monotherapy in a young subject with Prader-Willi syndrome, obesity, and type 2 diabetes: a case report
by: Elisa Dinoi, et al.
Published: (2025-02-01)

Murine typhus outbreak: Emergence of a new public health concerns in India
by: Mahendra Singh, et al.
Published: (2024-12-01)

Diagnostic study of fungal and bacterial pathogens that cause vaginal infection in women
by: Heba Hadid Rashed, et al.
Published: (2024-01-01)

The Effect of Rosuvastatin on a murine model of deep vein thrombosis
by: Megan E. Barney, et al.
Published: (2025-03-01)